Loading...
M12 logo

M1 Kliniken AGXTRA:M12 Stock Report

Market Cap €357.7m
Share Price
€19.28
€28
31.1% undervalued intrinsic discount
1Y35.6%
7D1.6%
1D
Portfolio Value
​
View

M1 Kliniken AG

XTRA:M12 Stock Report

Market Cap: €357.7m

M1 Kliniken (M12) Stock Overview

Provides aesthetic medicine and plastic surgery services in Germany, Austria, the Netherlands, Switzerland, Croatia, Hungary, Bulgaria, and Romania. More details

M12 fundamental analysis
Snowflake Score
Valuation3/6
Future Growth0/6
Past Performance5/6
Financial Health6/6
Dividends4/6

Rewards

Trading at 77.9% below our estimate of its fair value

Earnings grew by 38.2% over the past year

Risk Analysis

Dividend of 6.22% is not well covered by earnings


M12 Community Fair Values

Create Narrative

See what 20 others think this stock is worth. Follow their fair value or set your own to get alerts.

View all narratives

M1 Kliniken AG Competitors

Price History & Performance

Summary of share price highs, lows and changes for M1 Kliniken
Historical stock prices
Current Share Price€19.28
52 Week High€19.76
52 Week Low€12.78
Beta1.04
1 Month Change10.80%
3 Month Change21.26%
1 Year Change35.58%
3 Year Change141.00%
5 Year Change69.12%
Change since IPO285.68%

Recent News & Updates

Analysis Article • May 27

M1 Kliniken's (ETR:M12) Strong Earnings Are Of Good Quality

The subdued stock price reaction suggests that M1 Kliniken AG's ( ETR:M12 ) strong earnings didn't offer any surprises...

Recent updates

Analysis Article • May 27

M1 Kliniken's (ETR:M12) Strong Earnings Are Of Good Quality

The subdued stock price reaction suggests that M1 Kliniken AG's ( ETR:M12 ) strong earnings didn't offer any surprises...
Analysis Article • Dec 05

M1 Kliniken AG's (ETR:M12) P/E Is Still On The Mark Following 32% Share Price Bounce

M1 Kliniken AG ( ETR:M12 ) shares have continued their recent momentum with a 32% gain in the last month alone. Looking...
Analysis Article • Nov 21

The Return Trends At M1 Kliniken (ETR:M12) Look Promising

To find a multi-bagger stock, what are the underlying trends we should look for in a business? Ideally, a business will...
Analysis Article • Oct 14

At €15.74, Is M1 Kliniken AG (ETR:M12) Worth Looking At Closely?

While M1 Kliniken AG ( ETR:M12 ) might not have the largest market cap around , it received a lot of attention from a...
Analysis Article • Jun 13

Solid Earnings Reflect M1 Kliniken's (ETR:M12) Strength As A Business

M1 Kliniken AG's ( ETR:M12 ) strong earnings report was rewarded with a positive stock price move. We have done some...
Analysis Article • May 24

M1 Kliniken's (ETR:M12) Dividend Will Be €0.50

The board of M1 Kliniken AG ( ETR:M12 ) has announced that it will pay a dividend on the 21st of July, with investors...
Analysis Article • Oct 15

Does M1 Kliniken (ETR:M12) Have A Healthy Balance Sheet?

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
Analysis Article • Sep 24

Earnings Not Telling The Story For M1 Kliniken AG (ETR:M12) After Shares Rise 27%

M1 Kliniken AG ( ETR:M12 ) shareholders are no doubt pleased to see that the share price has bounced 27% in the last...
Analysis Article • Aug 03

Why We're Not Concerned Yet About M1 Kliniken AG's (ETR:M12) 27% Share Price Plunge

M1 Kliniken AG ( ETR:M12 ) shares have had a horrible month, losing 27% after a relatively good period beforehand...
Analysis Article • Jun 06

Additional Considerations Required While Assessing M1 Kliniken's (ETR:M12) Strong Earnings

Despite posting some strong earnings, the market for M1 Kliniken AG's ( ETR:M12 ) stock hasn't moved much. We did some...
Analysis Article • May 29

M1 Kliniken AG (ETR:M12) Looks Just Right With A 53% Price Jump

M1 Kliniken AG ( ETR:M12 ) shareholders have had their patience rewarded with a 53% share price jump in the last month...
Analysis Article • May 03

M1 Kliniken (ETR:M12) Might Be Having Difficulty Using Its Capital Effectively

There are a few key trends to look for if we want to identify the next multi-bagger. Ideally, a business will show two...
Analysis Article • Mar 07

At €14.40, Is It Time To Put M1 Kliniken AG (ETR:M12) On Your Watch List?

M1 Kliniken AG ( ETR:M12 ), might not be a large cap stock, but it saw a significant share price rise of 59% in the...
Analysis Article • Feb 18

Why Investors Shouldn't Be Surprised By M1 Kliniken AG's (ETR:M12) 25% Share Price Surge

Despite an already strong run, M1 Kliniken AG ( ETR:M12 ) shares have been powering on, with a gain of 25% in the last...
Analysis Article • Feb 17

Is M1 Kliniken AG (ETR:M12) Trading At A 46% Discount?

Key Insights Using the 2 Stage Free Cash Flow to Equity, M1 Kliniken fair value estimate is €23.97 Current share price...
Analysis Article • Sep 01

An Intrinsic Calculation For M1 Kliniken AG (ETR:M12) Suggests It's 27% Undervalued

Key Insights The projected fair value for M1 Kliniken is €11.44 based on 2 Stage Free Cash Flow to Equity M1 Kliniken...
Analysis Article • Jun 01

Should You Think About Buying M1 Kliniken AG (ETR:M12) Now?

M1 Kliniken AG ( ETR:M12 ), might not be a large cap stock, but it saw a significant share price rise of over 20% in...
Analysis Article • Mar 25

The Returns On Capital At M1 Kliniken (ETR:M12) Don't Inspire Confidence

What trends should we look for it we want to identify stocks that can multiply in value over the long term? Amongst...
Analysis Article • Dec 17

Investors Could Be Concerned With M1 Kliniken's (ETR:M12) Returns On Capital

If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...
Analysis Article • Nov 02

Is Now The Time To Look At Buying M1 Kliniken AG (ETR:M12)?

While M1 Kliniken AG ( ETR:M12 ) might not be the most widely known stock at the moment, it led the XTRA gainers with a...
Analysis Article • May 26

Time To Worry? Analysts Are Downgrading Their M1 Kliniken AG (ETR:M12) Outlook

One thing we could say about the analysts on M1 Kliniken AG ( ETR:M12 ) - they aren't optimistic, having just made a...
Analysis Article • May 25

Analysts Have Lowered Expectations For M1 Kliniken AG (ETR:M12) After Its Latest Results

As you might know, M1 Kliniken AG ( ETR:M12 ) recently reported its yearly numbers. M1 Kliniken missed revenue...
Analysis Article • Dec 06

Here's What's Concerning About M1 Kliniken's (ETR:M12) Returns On Capital

What trends should we look for it we want to identify stocks that can multiply in value over the long term? Firstly...
Analysis Article • May 22

There Are Reasons To Feel Uneasy About M1 Kliniken's (ETR:M12) Returns On Capital

To find a multi-bagger stock, what are the underlying trends we should look for in a business? Firstly, we'd want to...
Analysis Article • Mar 19

Here's What M1 Kliniken AG's (ETR:M12) Shareholder Ownership Structure Looks Like

Every investor in M1 Kliniken AG ( ETR:M12 ) should be aware of the most powerful shareholder groups. Institutions will...
Analysis Article • Feb 21

We're Watching These Trends At M1 Kliniken (ETR:M12)

If you're looking for a multi-bagger, there's a few things to keep an eye out for. In a perfect world, we'd like to see...
Analysis Article • Feb 03

M1 Kliniken (ETR:M12) Has Gifted Shareholders With A Fantastic 106% Total Return On Their Investment

When we invest, we're generally looking for stocks that outperform the market average. And in our experience, buying...
Analysis Article • Jan 16

Are Dividend Investors Getting More Than They Bargained For With M1 Kliniken AG's (ETR:M12) Dividend?

Could M1 Kliniken AG ( ETR:M12 ) be an attractive dividend share to own for the long haul? Investors are often drawn to...
Analysis Article • Dec 29

M1 Kliniken AG's (ETR:M12) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?

It is hard to get excited after looking at M1 Kliniken's (ETR:M12) recent performance, when its stock has declined 11...
Analysis Article • Dec 14

Here's Why We Don't Think M1 Kliniken's (ETR:M12) Statutory Earnings Reflect Its Underlying Earnings Potential

Broadly speaking, profitable businesses are less risky than unprofitable ones. Having said that, sometimes statutory...
Analysis Article • Nov 28

When Should You Buy M1 Kliniken AG (ETR:M12)?

While M1 Kliniken AG (ETR:M12) might not be the most widely known stock at the moment, it saw a double-digit share...

Shareholder Returns

M12DE HealthcareDE Market
7D1.6%-3.5%-0.3%
1Y35.6%-18.9%1.9%

Return vs Industry: M12 exceeded the German Healthcare industry which returned -19.1% over the past year.

Return vs Market: M12 exceeded the German Market which returned 2.3% over the past year.

Price Volatility

Is M12's price volatile compared to industry and market?
M12 volatility
M12 Average Weekly Movement6.4%
Healthcare Industry Average Movement6.7%
Market Average Movement6.0%
10% most volatile stocks in DE Market12.7%
10% least volatile stocks in DE Market2.7%

Stable Share Price: M12 has not had significant price volatility in the past 3 months compared to the German market.

Volatility Over Time: M12's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2007280Attila Strausswww.m1-kliniken.de

M1 Kliniken AG, together with its subsidiaries, provides aesthetic medicine and plastic surgery services in Germany, Austria, the Netherlands, Switzerland, Croatia, Hungary, Bulgaria, and Romania. It operates through Beauty and Trade segments. The Beauty segment provides aesthetic surgery services, such as breast augmentation, eyelid lifts, and liposuction; and other aesthetic medical treatment services, including injections with hyaluronic acid and botulinum toxin.

M1 Kliniken AG Fundamentals Summary

How do M1 Kliniken's earnings and revenue compare to its market cap?
M12 fundamental statistics
Market cap€357.74m
Earnings (TTM)€22.13m
Revenue (TTM)€364.30m
16.2x
P/E Ratio
1.0x
P/S Ratio

Is M12 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
M12 income statement (TTM)
Revenue€364.30m
Cost of Revenue€311.38m
Gross Profit€52.92m
Other Expenses€30.79m
Earnings€22.13m

Last Reported Earnings

Dec 31, 2025

Next Earnings Date

n/a

Earnings per share (EPS)1.19
Gross Margin14.53%
Net Profit Margin6.08%
Debt/Equity Ratio2.1%

How did M12 perform over the long term?

See historical performance and comparison

Dividends

6.2%
Current Dividend Yield
101%
Payout Ratio

Does M12 pay a reliable dividends?

See M12 dividend history and benchmarks
When do you need to buy M12 by to receive an upcoming dividend?
M1 Kliniken dividend dates
Ex Dividend DateJul 09 2026
Dividend Pay DateJul 13 2026
Days until Ex dividend36 days
Days until Dividend pay date40 days

Does M12 pay a reliable dividends?

See M12 dividend history and benchmarks

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/06/02 02:06
End of Day Share Price 2026/06/02 00:00
Earnings2025/12/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

M1 Kliniken AG is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Charlotte FriedrichsBerenberg
Ellis AcklinFirst Berlin Equity Research GmbH